Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Nicholas K Brownell , Boback Ziaeian , Gregg C Fonarow Added: 2 years ago

Heart Failure
Effects of S/V Therapy on Exercise Capacity in Patients with HFrEF
Author(s): Cinzia Nugara , Francesco Giallauria , Giuseppe Vitale , et al Added: 11 months ago

Imaging & Diagnostics

Heart Failure
Live stream of Novartis sponsored symposium ©2017
Start date: Apr 30, 2017
Live stream of Novartis sponsored symposium ©2017 Novartis Pharma AG, CH-4002 Basel – March 2017 – GLCM/HTF/0408 Sunday 30 April: Satellite Symposium → Sunday 30 April: Experts on the Spot → Please note this content is not intended for healthcare professionals licensed in the USA Please use Internet Explorer or Firefox browser to view the Live Stream --> Contemporary management… View more

Heart Failure
Contemporary Management Of Patients With HFrEF
Author(s): Faiez Zannad , John JV McMurray , Peter van der Meer , et al Added: 6 years ago
Topic Faculty 12:45–12:48 Welcome and introduction Faiez Zannad (France) and John McMurray (UK) 12:48–12:58 One year after updating the heart failure guidelines – has the management of patients with HFrEF changed? John McMurray (UK) 12:58–13:28 Managing contemporary HFrEF therapies – clinical case discussion Peter van der… View more

Heart Failure
Author(s): Andrew JS Coats , Mikhail Kosiborod Added: 1 year ago
This video series is dedicated to the adoption of patient-reported outcomes (PROs) and initiation of guideline-directed medical therapy (GDMT) in daily practice. In this first discussion,Prof Andrew Coats (Heart Research Institute, Sydney, AU) and Dr Mikhail Kosiborod (Saint Luke’s Mid America Heart Institute, Kansas City, US) address how to optimise clinical success using foundational… View more

Heart Failure
Sacubitril/Valsartan: Milestone in HFrEF Treatment
Author(s): Mauro Gori , James L Januzzi , Emilia D’Elia , et al Added: 3 years ago

Heart Failure
Lars Lund
Research Area(s) / Expertise: Job title: Associate Professor and Senior Consultant
Dr Lund's expertise is in HF big data and registry-based comparative outcomes studies and pragmatic trials. He is active in programs to improve utilisation of existing evidence-based interventions in heart failure with reduced ejection fraction, as well as in novel interventions. Dr Lars Lund is an Editorial Board member ofCardiac Failure Review. View more
image
Author(s): Gianluigi Savarese Added: 5 years ago
Dr Gianluigi Savarese (Solna, SE) discusses RASi in elderly patients with HFrEF -Association between renin-angiotensin system inhibitor use and mortality/morbidity in elderly patients with heart failure with reduced ejection fraction: a prospective propensity score-matched cohort. Filmed by Radcliffe Cardiology on site at HFA 2018 in Vienna, AT. View more

Heart Failure

CV Disease in Special Populations
Optimising Treatment Of Heart Failure
Author(s): Frank Ruschitzka , John JV McMurray , John R Teerlink Added: 6 years ago
Summary This Satellite Symposium - Experts on the Spot session titled ‘Optimising treatment of heart failure – where are we today?’ was moderated by Frank Ruschitzka. This session provided delegates the opportunity to ask questions to the expert faculty panelists; John McMurray and John Teerlink, following the two Novartis-sponsored Satellite Symposia on acute and chronic heart failure at ESC… View more

Heart Failure
ESC HF 21 Discussion: Vericiguat in Patients with AFIB and HF with HFrEF
Author(s): Harriette Van Spall , Piotr Ponikowski Added: 2 years ago
Late-breaker series host, Dr Harriette Van Spall (McMaster University, Hamilton, CA) sits down with Prof Piotr Ponikowski, professor of cardiology, Acting Rector, Vice-Rector for Scientific Affairs and the Head of Department of Heart Diseases at Wrocław Medical University, Poland. In this in-depth discussion on vericiguat in patients with atrial fibrillation and heart failure with reduced… View more

Heart Failure

Electrophysiology & Arrhythmia